Perspectum, an Oxford, England-based precision health company developing medical imaging tools to improve the diagnosis of metabolic diseases and cancer, completed $36 million in the first close of its Series C funding round. The round was led by Oppenheimer Holdings. With this, the total funding raised by the company accounts …

Tadaweb, a Luxembourg, Belval-based company that provides an open-source intelligence platform to transform how businesses generate intelligence from publicly available data, announced that it raised €15 million in a fresh round of funding to enable Tadaweb to grow to new levels. The funding came from Paris-based investment firm Wendel’s investment …

Product Science, a Los Angeles, CA-based startup that develops performance management software for apps, raised $18 million in funding. Backers in the round include Slow Ventures, Coatue, K5 Global, Mantis Ventures, Benchmark’s Peter Fenton, Insight Partners co-founder Jerry Murdock, and unnamed Snap VPs. “We realize that the industry will slow …

REM People, an Istanbul, Turkey-based company that focused on delivering “retail technologies & field audit services” to all sizes of companies that have physical sales operations in markets, stores, restaurants, and any type of point of sales, raised $12 million in funding. The investment was from the US-based project and …

Ganymed Robotics, a Paris, France-based developer of computer vision software and robotics technologies for orthopedic surgeons, announced it has extended its Series B with an additional €15 million, bringing the total Series B amount to €36 million. The Fund of the European Innovation Council, through its Accelerator Program, and Cap …

Wisdo Health, a Tel Aviv, Israel-based AI-powered social health platform harnessing the power of data and meaningful connections to improve health, raised $5 million in new funding, bringing its total Series A round to $11 million. The additional round was led by Marius Nacht, along with Alive Israel Healthtech Fund …

Onc.AI, a San Carlos, CA, and Canada-based technology company developing a novel digital clinical management solution focused on immuno-oncology, announced that it closed a $25 million Series A financing. The round was co-led by MassMutual and Action Potential Venture Capital (a GSK venture fund), with participation from Life Extension Ventures …